Extended Antiphospholipid Antibodies Screening in Systemic Lupus Erythematosus Patients

scientific article published in October 2015

Extended Antiphospholipid Antibodies Screening in Systemic Lupus Erythematosus Patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1515/RJIM-2015-0041
P698PubMed publication ID26939208

P50authorGheorghe-Andrei DanQ64518643
P2093author name stringR Ionescu
Anda Baicus
Simona Caraiola
Camelia Badea
Alina Dima
C Baicus
P Balanescu
C Jurcut
V Pompilian
Eugenia Balanescu
Doina Ramba
P2860cites workAnti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)Q24558202
Morbidity, mortality, and organ damage in patients with antiphospholipid syndrome.Q53137463
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Q28292418
The prevalence of antibodies to anionic phospholipids in patients with the primary antiphospholipid syndrome, systemic lupus erythematosus and their relatives and spousesQ33332505
The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosusQ33360375
Clinical manifestations and antiphosphatidylserine antibodies in patients with systemic lupus erythematosus: is there an association?Q33370780
The relevance of "non-criteria" clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical FeaturesQ33420116
Factors predictive of thrombotic events in LUMINA, a multi-ethnic cohort of SLE patients (LXXII).Q34169570
Antiphospholipid antibody tests: spreading the netQ35554909
Pathophysiological mechanisms in antiphospholipid syndromeQ36671159
Familial lupus and antiphospholipid syndromeQ36915627
Lupus anticoagulant activity of some antiphospholipid antibodies against phospholipid bound beta 2 glycoprotein IQ37237986
Pathophysiology of thrombotic APS: where do we stand?Q38013582
The contribution of antiphosphatidylethanolamine antibodies in the diagnosis of the antiphospholipid syndromeQ38013586
Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysisQ38177962
Two antiprothrombin antibodies against prothrombin and prothrombin-phosphatidyl serine show partial but not total identityQ40620711
Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysisQ41537096
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosusQ41977234
Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry".Q44550364
IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosisQ45126748
Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.Q45922457
Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.Q46008611
P275copyright licenseCreative Commons Attribution-NonCommercial-NoDerivs 3.0 UnportedQ19125045
P6216copyright statuscopyrightedQ50423863
P433issue4
P921main subjectsystemic lupus erythematosusQ1485
P304page(s)321-328
P577publication date2015-10-01
P1433published inRomanian journal of internal medicine = Revue roumaine de medecine interneQ27710040
P1476titleExtended Antiphospholipid Antibodies Screening in Systemic Lupus Erythematosus Patients
P478volume53

Reverse relations

Q89544090Impaired ankle-brachial index in antiphospholipid syndrome: Beyond the traditional risk factorscites workP2860

Search more.